Rolando Nortilli

Ki-67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosis

Annamaria Molino, Rocco Micciolo, Monica Turazza et al. · International Journal of Cancer · 1997 · 124 citations

Breast Oncology, Cancer Management, Immunology +16

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

Vanna Chiarion‐Sileni, Rolando Nortilli, Savina Aversa et al. · Melanoma Research · 2001 · 83 citations

Pharmacotherapy, Metronomic Chemotherapy, Dtic Arm +16

Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical Trial

Ruggero Ridolfi, Vanna Chiarion‐Sileni, Michele Guida et al. · Journal of Clinical Oncology · 2002 · 71 citations

Immunology, Pharmacotherapy, Immunotherapeutics +18

Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis

Annamaria Molino, Giuseppe Pelosi, Monica Turazza et al. · Breast Cancer Research and Treatment · 1997 · 68 citations

Bone Marrow Micrometastases, Breast Oncology, Breast Cancer Patients +9

Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods

A. Molino, Rocco Micciolo, Monica Turazza et al. · Breast Cancer Research and Treatment · 1997 · 68 citations

Estrogen Receptors, Tumor Biology, Breast Oncology +13